CLINICAL & PIPELINE·Drug Approval
MSN Laboratories Secures FDA Approval for Generic Oseltamivir Phosphate, Intensifying Market Competition
MSN Laboratories Private Limited received FDA approval for its Oseltamivir Phosphate generic capsules (ANDA212544) on May 20, 2020. This significant development introduces a new bioequivalent option in 30mg, 45mg, and 75mg strengths, enhancing supply chain diversity and competitive pricing for procurement directors. As an Indian API manufacturer, MSN's entry reinforces global generic supply dynamics.
90-Day Activity